ANRO (Alto Neuroscience) Total Assets: $276.26 Mil (As of Mar. 2026)


ANRO Alto Neuroscience Inc ANRO
12 GF Score
Price $27.04
! 2 Warning Signs
View Full Analysis

What is Alto Neuroscience Total Assets?

Alto Neuroscience ANRO +6.88% 12 Total Assets is $276.26 Mil as of Mar. 2026. GuruFocus rates ANRO with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Alto Neuroscience's Total Assets for the quarter that ended in Mar. 2026 was $276.26 Mil.

During the past 12 months, Alto Neuroscience's average Total Assets Growth Rate was -11.90% per year. During the past 3 years, the average Total Assets Growth Rate was 48.40% per year.

During the past 5 years, Alto Neuroscience's highest 3-Year average Total Assets Growth Rate was 48.40%. The lowest was 44.50%. And the median was 46.45%.

Total Assets is connected with ROA %. Alto Neuroscience's annualized ROA % for the quarter that ended in Mar. 2026 was -45.54%. Total Assets is also linked to Revenue through Asset Turnover. Alto Neuroscience's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Alto Neuroscience  (NYSE:ANRO) Total Assets Explanation

Total Assets is connected with ROA %.

Alto Neuroscience's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-104.948/( (184.689+276.259)/ 2 )
=-104.948/230.474
=-45.54 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Alto Neuroscience's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (184.689+276.259)/ 2 )
=0/230.474
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Alto Neuroscience Total Assets Related Terms

Alto Neuroscience Total Assets Historical Data

* Premium members only.

The historical data trend for Alto Neuroscience's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alto Neuroscience Total Assets Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
28.79 50.85 86.63 177.54 184.69

Alto Neuroscience Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.92 157.88 147.01 184.69 276.26
ANRO
12GF Score
Alto Neuroscience Inc ANRO
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alto Neuroscience Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Alto Neuroscience's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=151.142+33.547
=184.69

Alto Neuroscience's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=243.369+32.89
=276.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $276.26 Mil mean?
Alto Neuroscience (ANRO) has a Total Assets of $276.26 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Alto Neuroscience and its competitors.
Is Alto Neuroscience's Total Assets too high?
Alto Neuroscience's current Total Assets is $276.26 Mil. Overall, Alto Neuroscience has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Alto Neuroscience's Total Assets compare to MRVI and BBOT?
Alto Neuroscience's Total Assets of $276.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Alto Neuroscience and its competitors. Alto Neuroscience's current Total Assets is $276.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alto Neuroscience stock overvalued right now?
Alto Neuroscience (ANRO) has a current Total Assets of $276.26 Mil. The current Total Assets is $276.26 Mil. Alto Neuroscience's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Alto Neuroscience (ANRO), the current Total Assets is $276.26 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alto Neuroscience Business Description

Address 650 Castro Street, Suite 450, Mountain View, CA, USA, 94041
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
12GF Score

Get the complete analysis for ANRO

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.04
Price